• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化的进展形式:独特实体还是年龄依赖性现象?

Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena.

作者信息

Zeydan Burcu, Kantarci Orhun H

机构信息

Department of Neurology, Mayo Clinic and Foundation, 200 First Street, Southwest, Rochester, MN 55905, USA; Department of Radiology, Mayo Clinic and Foundation, 200 First Street, Southwest, Rochester, MN 55905, USA.

Department of Neurology, Mayo Clinic and Foundation, 200 First Street, Southwest, Rochester, MN 55905, USA.

出版信息

Neurol Clin. 2018 Feb;36(1):163-171. doi: 10.1016/j.ncl.2017.08.006.

DOI:10.1016/j.ncl.2017.08.006
PMID:29157397
Abstract

In multiple sclerosis (MS), disease course is defined by a subclinical or clinical relapsing remitting phase, a progressive phase, and the overlapping phase in-between. Each phase can have intermittently active or inactive periods. Subclinical activity in radiologically isolated syndrome evolving to primary-progressive MS is mostly indistinguishable from relapsing-remitting MS evolving to secondary-progressive MS. The onset of progressive-phase MS is age-dependent but time and pre-progressive phase agnostic. Pathologic hallmarks of progressive MS onset also appear to be age-dependent but pre-progressive phase agnostic. Onset of progressive MS is characterized by a peak in smoldering plaques.

摘要

在多发性硬化症(MS)中,疾病进程由亚临床或临床复发缓解期、进展期以及两者之间的重叠期来界定。每个阶段都可能有间歇性的活跃期或非活跃期。从放射学孤立综合征发展为原发进展型MS的亚临床活动,与从复发缓解型MS发展为继发进展型MS的情况大多难以区分。进展期MS的发病与年龄相关,但与时间和进展前期无关。进展型MS发病的病理特征似乎也与年龄相关,但与进展前期无关。进展型MS的发病特征是隐匿性斑块达到峰值。

相似文献

1
Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena.多发性硬化的进展形式:独特实体还是年龄依赖性现象?
Neurol Clin. 2018 Feb;36(1):163-171. doi: 10.1016/j.ncl.2017.08.006.
2
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.对白质多发性硬化斑块动态性质的临床与病理见解。
Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.
3
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.原发性进行性多发性硬化症由放射孤立综合征演变而来。
Ann Neurol. 2016 Feb;79(2):288-94. doi: 10.1002/ana.24564. Epub 2015 Dec 29.
4
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.进行性阶段的发病是多发性硬化症中一个与年龄相关的临床里程碑。
Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.
5
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
6
A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.一位已确诊的原发性进行性多发性硬化症患者,在经历一次暴发性脱髓鞘发作后,转变为“继发性”复发缓解型疾病过程。
Mult Scler. 2011 Oct;17(10):1262-4. doi: 10.1177/1352458510387183. Epub 2010 Dec 6.
7
T2 lesions and rate of progression of disability in multiple sclerosis.多发性硬化症中的 T2 病变和残疾进展率。
Eur J Neurol. 2010 Dec;17(12):1471-5. doi: 10.1111/j.1468-1331.2010.03093.x.
8
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.与多发性硬化症不同临床病程相关的发病机制。
Front Immunol. 2019 Jan 10;9:3116. doi: 10.3389/fimmu.2018.03116. eCollection 2018.
9
Relapsing and progressive forms of multiple sclerosis: insights from pathology.多发性硬化的复发缓解和进展形式:病理学的见解。
Curr Opin Neurol. 2014 Jun;27(3):271-8. doi: 10.1097/WCO.0000000000000094.
10
Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.原发进展型和复发缓解型多发性硬化症的相同病灶形态——一项超高场 MRI 研究。
Mult Scler. 2014 Dec;20(14):1866-71. doi: 10.1177/1352458514531084. Epub 2014 Apr 29.

引用本文的文献

1
Replication of the 2023 radiologically isolated syndrome criteria in a multi-centre cohort.2023年放射学孤立综合征标准在多中心队列中的验证
Brain Commun. 2025 Aug 28;7(5):fcaf323. doi: 10.1093/braincomms/fcaf323. eCollection 2025.
2
Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS.多方面生物标志物提示复发型和进展型多发性硬化症中枢神经系统病理学特征相似。
Eur J Neurol. 2025 Feb;32(2):e70052. doi: 10.1111/ene.70052.
3
CHI3L1 in Multiple Sclerosis-From Bench to Clinic.多发性硬化症中的几丁质酶3样蛋白1——从实验台到临床
Cells. 2024 Dec 17;13(24):2086. doi: 10.3390/cells13242086.
4
Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis.早期疾病修饰治疗用于多发性硬化症的无症状期。
CNS Drugs. 2024 Dec;38(12):973-983. doi: 10.1007/s40263-024-01117-9. Epub 2024 Sep 16.
5
New insights on the link between Epstein‑Barr virus infection and cognitive decline in neurodegenerative diseases (Review).爱泼斯坦-巴尔病毒感染与神经退行性疾病认知衰退之间联系的新见解(综述)
Exp Ther Med. 2024 Aug 30;28(5):413. doi: 10.3892/etm.2024.12702. eCollection 2024 Nov.
6
Imaging phenotypic differences in multiple sclerosis: at the crossroads of aging, sex, race, and ethnicity.多发性硬化症的影像学表型差异:处于衰老、性别、种族和族裔的交叉点
Front Glob Womens Health. 2024 Jun 28;5:1412482. doi: 10.3389/fgwh.2024.1412482. eCollection 2024.
7
Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis.原发性进行性多发性硬化症的疾病活动:一项系统评价和荟萃分析。
Front Neurol. 2023 Nov 6;14:1277477. doi: 10.3389/fneur.2023.1277477. eCollection 2023.
8
Impact of aging on treatment considerations for multiple sclerosis patients.衰老对多发性硬化症患者治疗考量的影响。
Front Neurol. 2023 Jul 7;14:1197212. doi: 10.3389/fneur.2023.1197212. eCollection 2023.
9
Probiotic-Fermented Camel Milk Attenuates Neurodegenerative Symptoms via SOX5/miR-218 Axis Orchestration in Mouse Models.益生菌发酵骆驼奶通过SOX5/miR-218轴调控减轻小鼠模型中的神经退行性症状。
Pharmaceuticals (Basel). 2023 Feb 25;16(3):357. doi: 10.3390/ph16030357.
10
The radiologically isolated syndrome: revised diagnostic criteria.放射学孤立综合征:修订后的诊断标准。
Brain. 2023 Aug 1;146(8):3431-3443. doi: 10.1093/brain/awad073.